* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mochida Pharmaceutical Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Mochida Pharmaceutical Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mochida Pharmaceutical Co (FRA:MFY) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Mochida Pharmaceutical Co and its competitors. According to the industry distribution chart, Mochida Pharmaceutical Co ranks #688 out of 958 companies in the Drug Manufacturers industry, placing it in the top 71.8%.
Is Mochida Pharmaceutical Co's FCF Margin % too high?
Mochida Pharmaceutical Co's current FCF Margin % is 0.00%. Based on the distribution chart, Mochida Pharmaceutical Co ranks #688 out of 958 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Mochida Pharmaceutical Co has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Mochida Pharmaceutical Co's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Mochida Pharmaceutical Co ranks #688 out of 958 companies for FCF Margin %. This places Mochida Pharmaceutical Co in the lower half of its industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Mochida Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mochida Pharmaceutical Co's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mochida Pharmaceutical Co stock overvalued right now?
Mochida Pharmaceutical Co (FRA:MFY) has a current FCF Margin % of 0.00%. The stock's GF Value™ is €19.65, compared to a current price of €16.70 — trading 15% below its estimated fair value. The current FCF Margin % is 0.00%. Mochida Pharmaceutical Co's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Mochida Pharmaceutical Co (FRA:MFY), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mochida Pharmaceutical Co (FRA:MFY) Overvalued in 2026?
Based on GuruFocus' analysis, Mochida Pharmaceutical Co stock appears to be undervalued.
The current stock price of €16.70 is trading 15% below its estimated GF Value™ of €19.65.
Key valuation signals for FRA:MFY:
FCF Margin %: 0.00%
GF Value™: €19.65 vs. price of €16.70 (15% below fair value)
No single metric tells the full story. See the FRA:MFY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
70GF Score
Get the complete analysis for FRA:MFY
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MFY has been successfully added to your 
